Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Clinical trial NCT01953640 · COMPLETED

Trial details

NCT number: NCT01953640
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Prostate Adenocarcinoma Recurrent Prostate Carcinoma

Start date: 2013-05-30
Primary completion: 2015-12-03
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.